The BIR Nuclear Medicine & Molecular Imaging SIG is a multidisciplinary team of dedicated and passionate nuclear medicine physicians, radionuclide radiologists, radiologists, radiographers clinical scientists/physicists, radiopharmacists, and clinical practitioners.
Specialists within the disciplines, such as clinical radionuclide imaging, and molecular radiotherapy, education & research are also represented in the group.
The SIG promotes and facilitates teaching and research in nuclear medicine and molecular Imaging. The committee regularly organises scientific meetings to meet the educational needs of medical imaging professionals (from trainees through to consultants).
Within the BIR, the group advises the BIR council on matters or documents relating to radionuclide imaging (conventional and hybrid imaging) and radionuclide therapies. In addition, it advises on documents from other professional bodies.
Pictured from left: Vicki Parkin, Dan McGowan, Cherry Sit, Amy Eccles, Connor Ferris, Allison Craig, Shaunak Navalkissoor (Chair) and Glafkos Havariyoun.
Latest SIG News
Update from June 2017 meeting
The group had a productive and lively meeting on 30 June and discussed their upcoming events, webinar proposals, a special issue being produced for BJR and other matters:
- Theranostics study day – planned for 5th February 2018
- The bi-annual meeting BIR/IDUG meeting on Molecular Radiotherapy Imaging would be put on again in mid 2018
- Dementia Imaging meeting, planned for 2018
- Special issue is being put together for BJR on Theranostics
- The SIG were planning a series of webinars on PET CT – watch out for more details
- Podcasts – a number of these had been recorded, including some from the last SPECT CT meeting held in February 2017: http://www.bir.org.uk/education-and-events/podcasts-and-postercasts/
- A survey on PPRT (Peptide Receptor Radionuclide Therapy) has been sent out: PPRT SURVEY. Do go to the link and complete the survey by 31st August 2017.
- The BIR had worked with Media Planet to produce a supplement on the Future of Radiotherapy which had been distributed by the Guardian in June. The NMMI SIG were looking to produce a similar paper on Radionuclide Therapy. Watch out for more details.
The BIR endorse the guidance written by the British Nuclear Medicine Society (BNMS) on scientific support for nuclear medicine. This document highlights the vitally important role of clinical scientists in the nuclear medicine workforce. The guidelines are available at: http://www.bnms.org.uk/images/Scientific Support for NuclearMedicine Report March 2016